GLYC
Price
$0.18
Change
-$0.00 (-0.00%)
Updated
Apr 7, 04:59 PM (EDT)
Capitalization
11.37M
23 days until earnings call
LYRA
Price
$0.11
Change
-$0.01 (-8.33%)
Updated
Apr 7 closing price
Capitalization
7.37M
35 days until earnings call
Ad is loading...

GLYC vs LYRA

Header iconGLYC vs LYRA Comparison
Open Charts GLYC vs LYRABanner chart's image
GlycoMimetics
Price$0.18
Change-$0.00 (-0.00%)
Volume$100
Capitalization11.37M
Lyra Therapeutics
Price$0.11
Change-$0.01 (-8.33%)
Volume$2.48M
Capitalization7.37M
GLYC vs LYRA Comparison Chart
Loading...
GLYC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LYRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GLYC vs. LYRA commentary
Apr 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GLYC is a Buy and LYRA is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 08, 2025
Stock price -- (GLYC: $0.18 vs. LYRA: $0.12)
Brand notoriety: GLYC and LYRA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GLYC: 51% vs. LYRA: 432%
Market capitalization -- GLYC: $11.37M vs. LYRA: $7.37M
GLYC [@Biotechnology] is valued at $11.37M. LYRA’s [@Biotechnology] market capitalization is $7.37M. The market cap for tickers in the [@Biotechnology] industry ranges from $283.55B to $0. The average market capitalization across the [@Biotechnology] industry is $2.18B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GLYC’s FA Score shows that 0 FA rating(s) are green whileLYRA’s FA Score has 1 green FA rating(s).

  • GLYC’s FA Score: 0 green, 5 red.
  • LYRA’s FA Score: 1 green, 4 red.
According to our system of comparison, LYRA is a better buy in the long-term than GLYC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GLYC’s TA Score shows that 4 TA indicator(s) are bullish while LYRA’s TA Score has 4 bullish TA indicator(s).

  • GLYC’s TA Score: 4 bullish, 6 bearish.
  • LYRA’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, both GLYC and LYRA are a bad buy in the short-term.

Price Growth

GLYC (@Biotechnology) experienced а -17.51% price change this week, while LYRA (@Biotechnology) price change was -13.17% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -9.12%. For the same industry, the average monthly price growth was -17.78%, and the average quarterly price growth was -18.34%.

Reported Earning Dates

GLYC is expected to report earnings on May 01, 2025.

LYRA is expected to report earnings on May 13, 2025.

Industries' Descriptions

@Biotechnology (-9.12% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GLYC($11.4M) has a higher market cap than LYRA($7.37M). GLYC YTD gains are higher at: -27.711 vs. LYRA (-41.570). GLYC has higher annual earnings (EBITDA): -32.47M vs. LYRA (-60.26M). LYRA has more cash in the bank: 40.6M vs. GLYC (10.7M). GLYC has less debt than LYRA: GLYC (66.8K) vs LYRA (34.4M). LYRA has higher revenues than GLYC: LYRA (1.53M) vs GLYC (0).
GLYCLYRAGLYC / LYRA
Capitalization11.4M7.37M155%
EBITDA-32.47M-60.26M54%
Gain YTD-27.711-41.57067%
P/E RatioN/AN/A-
Revenue01.53M-
Total Cash10.7M40.6M26%
Total Debt66.8K34.4M0%
FUNDAMENTALS RATINGS
GLYC: Fundamental Ratings
GLYC
OUTLOOK RATING
1..100
55
VALUATION
overvalued / fair valued / undervalued
1..100
88
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GLYCLYRA
RSI
ODDS (%)
Bullish Trend 7 days ago
86%
Bullish Trend 7 days ago
81%
Stochastic
ODDS (%)
Bullish Trend 7 days ago
80%
Bullish Trend 7 days ago
90%
Momentum
ODDS (%)
Bearish Trend 7 days ago
88%
Bearish Trend 7 days ago
88%
MACD
ODDS (%)
Bearish Trend 7 days ago
88%
Bearish Trend 7 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 7 days ago
88%
Bearish Trend 7 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 7 days ago
89%
Bearish Trend 7 days ago
88%
Advances
ODDS (%)
Bullish Trend 20 days ago
83%
Bullish Trend 18 days ago
82%
Declines
ODDS (%)
Bearish Trend 7 days ago
86%
Bearish Trend 7 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 7 days ago
79%
Bullish Trend 7 days ago
90%
Aroon
ODDS (%)
Bearish Trend 7 days ago
87%
Bearish Trend 7 days ago
89%
View a ticker or compare two or three
Ad is loading...
GLYC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LYRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME23.492.39
+11.33%
GameStop Corp
SPY505.28-31.42
-5.85%
SPDR® S&P 500® ETF Trust
BTC.X78214.484000-5290.312500
-6.34%
Bitcoin cryptocurrency
AAPL188.38-14.81
-7.29%
Apple
TSLA239.43-27.85
-10.42%
Tesla

GLYC and

Correlation & Price change

A.I.dvisor indicates that over the last year, GLYC has been closely correlated with LYRA. These tickers have moved in lockstep 76% of the time. This A.I.-generated data suggests there is a high statistical probability that if GLYC jumps, then LYRA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GLYC
1D Price
Change %
GLYC100%
-2.76%
LYRA - GLYC
76%
Closely correlated
+8.55%
ROQAF - GLYC
72%
Closely correlated
N/A
EYPT - GLYC
46%
Loosely correlated
-7.62%
IONS - GLYC
35%
Loosely correlated
-5.01%
ALLO - GLYC
33%
Loosely correlated
+4.35%
More

LYRA and

Correlation & Price change

A.I.dvisor indicates that over the last year, LYRA has been closely correlated with ROQAF. These tickers have moved in lockstep 85% of the time. This A.I.-generated data suggests there is a high statistical probability that if LYRA jumps, then ROQAF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LYRA
1D Price
Change %
LYRA100%
+8.55%
ROQAF - LYRA
85%
Closely correlated
N/A
GLYC - LYRA
76%
Closely correlated
-2.76%
EYPT - LYRA
58%
Loosely correlated
-7.62%
HSTC - LYRA
29%
Poorly correlated
N/A
BCYC - LYRA
27%
Poorly correlated
-7.27%
More